Pall's eBDS System receives CE Mark

By Lisa Kerner

Charlotte, N.C., Sept. 5 - Pall Corp. announced that its eBDS System to detect contamination of red blood cells has received the CE Mark.

Blood centers use the culture-based test to detect bacterial contamination of platelets, a leading infectious cause of sickness and death from a transfusion, the East Hills, N.Y. medical-device company said.

Results from a new study presented at the International Society of Blood Transfusion 2006 Congress demonstrated the efficacy of the system in detecting bacteria in 662 red blood cell samples.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.